Immunologic impact of the intestine in metabolic disease.

about

Evidences of a New Psychobiotic Formulation on Body Composition and Anxiety.Microscopic colitis-microbiome, barrier function and associated diseases.Inflammatory Bowel Disease and Immunonutrition: Novel Therapeutic Approaches Through Modulation of Diet and the Gut Microbiome.

P2860

Q48048747-63B7A3FA-7184-4CE3-8626-A2388D29171C Q52333906-6B6A6D01-AF85-400D-8A5B-F12A02E6816B Q52564079-207E3215-66A9-422A-8441-F229306B46E1

P2860

Immunologic impact of the intestine in metabolic disease.

Item

http://www.wikidata.org/entity/Q39065615

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Immunologic impact of the intestine in metabolic disease.

@en

Immunologic impact of the intestine in metabolic disease.

@nl

type

Item

label

Immunologic impact of the intestine in metabolic disease.

@en

Immunologic impact of the intestine in metabolic disease.

@nl

prefLabel

Immunologic impact of the intestine in metabolic disease.

@en

Immunologic impact of the intestine in metabolic disease.

@nl

P1476

Immunologic impact of the intestine in metabolic disease.

@en

P2093

Daniel A Winer

http://www.w3.org/2001/XMLSchema#string

Helen J Dranse

http://www.w3.org/2001/XMLSchema#string

Shawn Winer

http://www.w3.org/2001/XMLSchema#string

Tony K T Lam

http://www.w3.org/2001/XMLSchema#string

P2860

High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse

B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

Fate mapping of IL-17-producing T cells in inflammatory responses

Physiology and immunology of the cholinergic antiinflammatory pathway

Intestinal Immunity and Gut Microbiota as Therapeutic Targets for Preventing Atherosclerotic Cardiovascular Diseases

An obesity-associated gut microbiome with increased capacity for energy harvest

Obesity is associated with macrophage accumulation in adipose tissue

Induction of intestinal Th17 cells by segmented filamentous bacteria

P304

33-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI88879

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28045403

http://www.w3.org/2001/XMLSchema#string

P932

5199708

http://www.w3.org/2001/XMLSchema#string

Immunologic impact of the intestine in metabolic disease.

about

P2860

P2860

Immunologic impact of the intestine in metabolic disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932